The Evidence Based Rheumatology Podcast

← The Evidence Based Rheumatology Podcast22 dic 2025 · 13 min

E130: Telitacicept for SLE

E130: Telitacicept for SLE22 dic 202513 min

Surprisingly (unbelievably?) impressive RCT evaluating the Blys/APRIL inhibitor "telitacicept" for patients with SLE (mixed SLE and SLE-LN). Very curious to see where the FDA goes with this one.

Paper: https://www.nejm.org/doi/full/10.1056/NEJMoa2414719